4/24/2015 - 3:42 PM EST - T-Bird Pharma Inc. : announced that it, together with certain of its shareholders, has closed the transaction announced on March 11 with Medna Biosciences Inc.. Medna has acquired a total of 20,156,790 common shares of T-Bird (45% of the Company's issued shares) from five of its founding shareholders, including its former CEO and CFO, at a price of $0.21 per share. T-Bird Pharma Inc.
shares V.TPI are trading down $0.02 at $0.48.
